Department of Public Health & Community Medicine, Tufts University School of Medicine, Boston, MA, United States of America.
Department of Public Health & Community Medicine, Tufts University School of Medicine, Boston, MA, United States of America.
Prev Med. 2022 Jan;154:106905. doi: 10.1016/j.ypmed.2021.106905. Epub 2021 Dec 1.
Early studies suggest that adults with mental health conditions are at greater risk for COVID-19 infection, severe complications, and higher mortality, yet face barriers in accessing timely health services. Data from the Census Bureau's Household Pulse Survey, a large, nationally representative survey fielded from March 17-29, 2021 (n = 77,104) were analyzed to examine COVID-19 vaccination and intention among adults with mental health symptoms. Separate multivariable regression models were conducted to examine associations between symptoms of anxiety, depression, and anxiety or depression on vaccine receipt (≥ 1 dose) and intention to be vaccinated. Reasons for not being vaccinated were also assessed. Approximately 35% of adults had symptoms of anxiety or depression. This population was less likely to receive COVID-19 vaccination (adjusted prevalence ratio (aPR) = 0.94, 95%CI: 0.91-0.98) but more likely to intend to get a vaccine (aPR = 1.13, 95%CI: 1.08-1.19) than those without these conditions. Females with mental health symptoms were less likely to receive a COVID-19 vaccination but more likely to intend to get vaccinated, while there were fewer significant associations between mental health symptoms and vaccination coverage and intentions to vaccinate among males. Reasons for not getting vaccinated, including concerns about possible vaccine side effects, efficacy, cost, dislike of vaccines, as well as lack of trust in the government and vaccines, were all greater among those with any symptoms of anxiety or depressive disorders than those without symptoms. Efforts are needed to increase vaccination uptake and confidence among this vulnerable population by increasing vaccine confidence and addressing concerns about the vaccine.
早期研究表明,患有精神健康状况的成年人感染 COVID-19、出现严重并发症和死亡率更高的风险更大,但在获得及时的医疗服务方面面临障碍。对人口普查局的家庭脉搏调查(一项大规模的全国代表性调查,于 2021 年 3 月 17 日至 29 日进行)的数据进行了分析,以检查有精神健康症状的成年人对 COVID-19 疫苗的接种和接种意愿。分别进行多变量回归模型,以检查焦虑、抑郁症状以及焦虑或抑郁症状与疫苗接种(至少一剂)和接种意愿之间的关联。还评估了未接种疫苗的原因。大约 35%的成年人有焦虑或抑郁症状。这部分人群接种 COVID-19 疫苗的可能性较低(调整后患病率比(aPR)=0.94,95%CI:0.91-0.98),但更有可能打算接种疫苗(aPR=1.13,95%CI:1.08-1.19),而不是没有这些情况的人群。有精神健康症状的女性接种 COVID-19 疫苗的可能性较低,但更有可能打算接种疫苗,而男性中精神健康症状与疫苗接种率和接种意愿之间的关联则较少。未接种疫苗的原因包括对可能的疫苗副作用、疗效、成本、对疫苗的反感,以及对政府和疫苗缺乏信任等,在有任何焦虑或抑郁障碍症状的人群中比没有症状的人群更为常见。需要努力提高这一弱势群体对疫苗的信心并解决对疫苗的担忧,以增加疫苗接种率和信心。